The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originated in
Wuhan, China in late 2019, and its resulting coronavirus disease, COVID-19, was declared a …

Four isolates of Klebsiella pneumoniae obtained from patients at a Maryland medical centre
exhibited reduced susceptibility to carbapenems and were found to produce the novel, class …

Background Aerosol transmission of COVID-19 is the subject of ongoing policy debate.
Characterizing aerosol produced by people with COVID-19 is critical to understanding the role of …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission causing
coronavirus disease 2019 (COVID-19) may occur through multiple routes. We collected aerosol …

Rapid, reliable, and easy-to-use diagnostic assays for detection of Zaire ebolavirus (ZEBOV)
are urgently needed. The goal of this study was to examine the agreement among …

Reference to the Ebola virus causes concern among all individuals, whether from the public
or within the medical community. Realization that patients with Ebola virus disease (EVD) …

The COVID-19 pandemic has reintroduced questions regarding the potential risk of SARS-CoV-2
exposure amongst passengers on an aircraft. Quantifying risk with computational fluid …

Beginning in 2003, the Nebraska Medical Center in Omaha developed a laboratory
capability plan in conjunction with the creation of a biocontainment unit (BCU) for treatment of …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is transmitted human-to-human
via aerosols and air-borne droplets. Therefore, capturing and destroying viruses from …

As the world recovers from the lockdown imposed by the Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) pandemic, returning to shared indoor spaces is considered …